How to implement a clinical pathway for intensive glucose regulation in acute coronary syndromes

Critical Pathways in Cardiology

Volumn 8, Issue 2, 2009, Pages 72-78

  De Mulder, Maarten ^a   Zwaan, Esther ^a   Wielinga, Yvonne ^a   Stam, Frank ^a   Umans, Victor A W M ^a  

^a Location Alkmaar   (Netherlands)

Author keywords

Glucose regulation; Insulin; Myocardial infarction; Pathway implementation; Protocol

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN ASPART;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY CARE UNIT; DISEASE SEVERITY; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEAL; MEASUREMENT; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CRITICAL PATHWAYS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN;

EID: 68049105362     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3181a3e577     Document Type: Article

References (24)

1. Bolk J, van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207-214.
2. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111:3078-3086.
3. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-778.
4. Kadri Z, Danchin N, Vaur L, et al. Major impact of admission glycaemia on 30 day and one year mortality in non-diabetic patients admitted for myocardial infarction: results from the nationwide French USIC. 2000 study. Heart. 2006;92:910-915.
5. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
6. Malmberg K; DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512-1515.
7. Diaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298:2399-2405.
8. Mehta RH, Montoye CK, Gallogly M, et al. Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) Initiative. JAMA. 2002;287:1269-1276.
9. De Mulder M, Oemrawsingh RM, Stam F, et al. Current management of hyperglycemia in acute coronary syndromes, a national Dutch survey. Crit Pathw Cardiol. 2009;8:66-71.
10. Nobels F, van Pottelbergh I, van Crombrugge P. Essentials of insulin therapy in diabetes mellitus. Alphen aan den Rijn: Van Zuiden communications BV, 2006.
11. Lecomte P, Foubert L, Nobels F, et al. Dynamic tight glycemic control during and after cardiac surgery is effective, feasible, and safe. Anesth Analg. 2008;107:51-58.
12. Bode BW, Braithwaite SS, Steed RD, et al. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004;10(suppl 2):71-80.
13. Vogelzang M, van der Horst I, Nijsten MW. Hyperglycaemic index as a tool to assess glucose control: a retrospective study. Crit Care. 2004;8:R122-R127.
14. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-770.
15. Weston C, Walker L, Birkhead J. Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome. Heart. 2007;93:1542-1546.
16. Mellbin LG, Malmberg K, Norhammar A, et al. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J. 2008;29:166-176.
17. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300:933-944.
18. Vogelzang M, Loef BG, Regtien JG, et al. Computer-assisted glucose control in critically ill patients. Intensive Care Med. 2008;34:1421-1427.
19. Pinto DS, Skolnick AH, Kirtane AJ, et al. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2005;46:178-180.
20. Kosiborod M, Inzucchi SE, Krumholz HM, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117:1018-1027.
21. Meijering S, Corstjens AM, Tulleken JE, et al. Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature. Crit Care. 2006;10:R19.
22. Goldberg PA, Sakharova OV, Barrett PW, et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothorac Vasc Anesth.2004;18:690-697.
23. Malmberg KA, Efendic S, Ryden LE. Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI. Diabetes Care. 1994;17:1007-1014.
24. Cannon CP, Ornato JP. How to develop a critical pathway: the Acute Coronary Syndromes: Acute Cardiac Team to Implement Optimal Treatments Now (ACS ACTION) Program. Crit Pathw Cardiol. 2002;1:53-60.